LIDOCAINE Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline. (Chemical Entities of Biological Interest Ontology, CHEBI_6456)
External Link https://dgidb.org/results?searchType=drug&searchTerms=LIDOCAINE
Similar Terms
Downloads & Tools

Genes

16 interacting proteins for the LIDOCAINE drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
SLC1A1 solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 0.472607
MPO myeloperoxidase 0.189043
SCN5A sodium channel, voltage gated, type V alpha subunit 0.187259
SCN10A sodium channel, voltage gated, type X alpha subunit 0.109063
SCN9A sodium channel, voltage gated, type IX alpha subunit 0.104471
SCN11A sodium channel, voltage gated, type XI alpha subunit 0.10025
BDNF brain-derived neurotrophic factor 0.0624198
SCN7A sodium channel, voltage gated, type VII alpha subunit 0.056072
SCN3A sodium channel, voltage gated, type III alpha subunit 0.0453185
SCN4A sodium channel, voltage gated, type IV alpha subunit 0.0435296
SCN2A sodium channel, voltage gated, type II alpha subunit 0.0435296
SCN8A sodium channel, voltage gated, type VIII alpha subunit 0.0429643
SCN1A sodium channel, voltage gated, type I alpha subunit 0.0424135
G6PD glucose-6-phosphate dehydrogenase 0.0334167
CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4 0.0149357
EGFR epidermal growth factor receptor 0.0113686